Campylobacter

Vaccine Trial Initiated

Published in Vaccine Weekly, October 7th, 1996

Antex Biologics, Gaithersburg, Maryland, announced that it has begun a clinical trial of an orally administered Campylobacter vaccine in combination with a mucosal adjuvant for the prevention of gastroenteritis and diarrhea.

The objective of this randomized, double-blinded clinical comprised of approximately 100 volunteers is to determine the safety and immunogenicity of the vaccine and adjuvant combination. "Pre-clinical animal studies have demonstrated that mucosal immunity is critical to the effectiveness of oral vaccines against intestinal pathogens like Campylobacter," said Dr. Vic Esposito, Antex.

"Previously we completed a Phase...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1996-10-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry